Filed: 5/15/2026ACC: 0002111609-26-000002
📋 What this filing means
ISHARA INVESTMENTS LP filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $105.63M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$105.63M
Total AUM (reported)
8.20M
Total Shares
Allocation by class
COM$68.19M64.6%
COM NEW$21.26M20.1%
CL A$5.15M4.9%
SPONSORED ADS$4.34M4.1%
CLASS A ORD$3.25M3.1%
SHS$1.51M1.4%
ORDINARY SHARES$1.18M1.1%
Portfolio Concentration
Top 3$26.75M25.3%
4–10$30.34M28.7%
11–25$36.73M34.8%
Rest$11.81M11.2%
Top 3 weight
25.3%
Top 10 weight
54.0%
Voting Authority Distribution
Total shares with voting rights: 8.20M
Sole
Full voting authority
8.20M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole36
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
PRAXIS PRECISION MEDICINES I
SOLEShares43.05K
TypeSH
Market value$13.87M
13.13%
Sole
43.05K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC.
SOLEShares41K
TypeSH
Market value$6.93M
6.56%
Sole
41K
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares1.02M
TypeSH
Market value$5.95M
5.63%
Sole
1.02M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares276.75K
TypeSH
Market value$5.57M
5.27%
Sole
276.75K
Shared
0.00
None
0.00
AMICUS THERAPEUTIC
SOLEShares369K
TypeSH
Market value$5.34M
5.05%
Sole
369K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares82K
TypeSH
Market value$4.63M
4.39%
Sole
82K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares820K
TypeSH
Market value$4.35M
4.11%
Sole
820K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares174.25K
TypeSH
Market value$3.65M
3.46%
Sole
174.25K
Shared
0.00
None
0.00
ARROWHEAD PHARMACEUTICALS IN
SOLEShares55.35K
TypeSH
Market value$3.47M
3.29%
Sole
55.35K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares57.40K
TypeSH
Market value$3.34M
3.16%
Sole
57.40K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares82K
TypeSH
Market value$3.30M
3.12%
Sole
82K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares110.70K
TypeSH
Market value$3.29M
3.11%
Sole
110.70K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares174.25K
TypeSH
Market value$3.25M
3.08%
Sole
174.25K
Shared
0.00
None
0.00
ZENTALIS PHARMACEUTICALS INC
SOLEShares1.23M
TypeSH
Market value$2.88M
2.72%
Sole
1.23M
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares57.40K
TypeSH
Market value$2.82M
2.67%
Sole
57.40K
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares123K
TypeSH
Market value$2.74M
2.59%
Sole
123K
Shared
0.00
None
0.00
ARDELYX INC
SOLEShares451K
TypeSH
Market value$2.70M
2.56%
Sole
451K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares82K
TypeSH
Market value$2.22M
2.10%
Sole
82K
Shared
0.00
None
0.00
GENMAB A/S
SOLEShares82K
TypeSH
Market value$2.20M
2.08%
Sole
82K
Shared
0.00
None
0.00
DBV TECHNOLOGIES S A
SOLEShares102.50K
TypeSH
Market value$2.14M
2.03%
Sole
102.50K
Shared
0.00
None
0.00
CATALYST PHARMACEUTICALS INC
SOLEShares82K
TypeSH
Market value$2.03M
1.92%
Sole
82K
Shared
0.00
None
0.00
SIONNA THERAPEUTICS INC
SOLEShares49.20K
TypeSH
Market value$1.97M
1.87%
Sole
49.20K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares142K
TypeSH
Market value$1.85M
1.76%
Sole
142K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares5.13K
TypeSH
Market value$1.70M
1.61%
Sole
5.13K
Shared
0.00
None
0.00
LIGAND PHARMACEUTICALS INC
SOLEShares8.20K
TypeSH
Market value$1.64M
1.55%
Sole
8.20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 43.05K | SH | $13.87M 13.13% | 43.05K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INC.SOLE | COM | 41K | SH | $6.93M 6.56% | 41K | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 1.02M | SH | $5.95M 5.63% | 1.02M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 276.75K | SH | $5.57M 5.27% | 276.75K | 0.00 | 0.00 |
AMICUS THERAPEUTICSOLE | COM | 369K | SH | $5.34M 5.05% | 369K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 82K | SH | $4.63M 4.39% | 82K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 820K | SH | $4.35M 4.11% | 820K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 174.25K | SH | $3.65M 3.46% | 174.25K | 0.00 | 0.00 |
ARROWHEAD PHARMACEUTICALS INSOLE | COM | 55.35K | SH | $3.47M 3.29% | 55.35K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 57.40K | SH | $3.34M 3.16% | 57.40K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 82K | SH | $3.30M 3.12% | 82K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 110.70K | SH | $3.29M 3.11% | 110.70K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 174.25K | SH | $3.25M 3.08% | 174.25K | 0.00 | 0.00 |
ZENTALIS PHARMACEUTICALS INCSOLE | COM | 1.23M | SH | $2.88M 2.72% | 1.23M | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 57.40K | SH | $2.82M 2.67% | 57.40K | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 123K | SH | $2.74M 2.59% | 123K | 0.00 | 0.00 |
ARDELYX INCSOLE | COM | 451K | SH | $2.70M 2.56% | 451K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 82K | SH | $2.22M 2.10% | 82K | 0.00 | 0.00 |
GENMAB A/SSOLE | SPONSORED ADS | 82K | SH | $2.20M 2.08% | 82K | 0.00 | 0.00 |
DBV TECHNOLOGIES S ASOLE | SPONSORED ADS | 102.50K | SH | $2.14M 2.03% | 102.50K | 0.00 | 0.00 |
CATALYST PHARMACEUTICALS INCSOLE | COM | 82K | SH | $2.03M 1.92% | 82K | 0.00 | 0.00 |
SIONNA THERAPEUTICS INCSOLE | COM | 49.20K | SH | $1.97M 1.87% | 49.20K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 142K | SH | $1.85M 1.76% | 142K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 5.13K | SH | $1.70M 1.61% | 5.13K | 0.00 | 0.00 |
LIGAND PHARMACEUTICALS INCSOLE | COM NEW | 8.20K | SH | $1.64M 1.55% | 8.20K | 0.00 | 0.00 |
Page 1 of 2